Meldonium
$ 40,00 – $ 324,00Price range: $ 40,00 through $ 324,00
Meloset
$ 11,00 – $ 52,00Price range: $ 11,00 through $ 52,00
Mellaril
$ 40,00 – $ 427,00Price range: $ 40,00 through $ 427,00
Mellaril, containing the active ingredient thioridazine, is a potent antipsychotic medication belonging to the phenothiazine class. It is primarily indicated for the management of symptoms associated with schizophrenia in adult patients. This medication works by balancing specific natural substances in the brain to help reduce disorganized thinking and emotional instability. By effectively managing these psychiatric symptoms, it assists individuals in improving their overall daily functioning and social interactions. Mellaril is typically reserved for those who have not responded adequately to other psychiatric treatments, providing a targeted approach for complex mental health conditions.
Active substance: Thioridazine
SKU:
Mellaril
Categories: AntiDepressants, AntiPsychotic
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Mellaril contains thioridazine hydrochloride, a prescription medication belonging to the typical piperidine phenothiazine class of antipsychotics. It works primarily within the central nervous system by modulating neurotransmitter activity, specifically dampening central dopamine receptor signals.
Because of documented cardiac risks, the United States Food and Drug Administration (FDA) classifies Mellaril as a prescription-only treatment indicated strictly for adult patients with schizophrenia who have failed to respond adequately to alternative antipsychotic medications.
| Parameter | Details |
|---|---|
| Active ingredient (INN) | Thioridazine hydrochloride |
| Therapeutic class | Phenothiazine antipsychotic |
| Dosage form | Oral tablet |
| Route of administration | Oral |
| Prescription status | Prescription only (Rx) |
| Primary purpose | Management of refractory schizophrenia in adults |
Clinical Overview and Pharmacologic Characteristics
How the drug works
Mellaril exerts its therapeutic effects predominantly through the blockade of post-synaptic dopamine D2 receptors within the mesolimbic and cortical pathways of the brain. Thioridazine hydrochloride also displays significant binding affinity for histamine H1, muscarinic acetylcholine, and alpha-1 adrenergic receptors, which accounts for both its broader pharmacologic activity and secondary systemic effects. By dampening excessive central dopaminergic neurotransmission, the compound assists in reducing hallucinations, delusions, and severe thought disorganization associated with psychotic disorders. However, its anticholinergic and sedative properties are noticeably more pronounced compared to high-potency antipsychotic agents.
Main uses
The primary FDA-approved indication for Mellaril is the management of adult patients diagnosed with schizophrenia who do not demonstrate an adequate response to standard trials of other antipsychotic drugs. Due to the established risk of QTc interval prolongation, Mellaril is not indicated as a first-line therapy. Its application is restricted to refractory cases where alternative medications have proven ineffective or caused intolerable adverse events. Off-label prescribing of thioridazine for anxiety, pediatric behavioral conditions, insomnia, or general agitation is strongly discouraged under modern clinical guidelines due to the associated risk of life-threatening cardiac arrhythmias.
Dosing schedule
Dosing must be strictly individualized based on the clinical severity of the condition and observed patient response under licensed medical supervision. For adults with refractory schizophrenia, treatment typically initiates at a lower daily dose divided into two to four administrations. Dosages may be incrementally adjusted in a controlled environment until clinical stabilization is reached. Total daily oral doses generally range between 200 mg and 800 mg per day, divided into multiple doses throughout the day. The absolute maximum daily dose limit of 800 mg must not be exceeded due to a steep, dose-dependent rise in cardiotoxicity risks.
What happens in the body
Following oral administration, thioridazine hydrochloride is rapidly absorbed from the gastrointestinal tract, achieving peak plasma concentrations within 1 to 4 hours. The compound undergoes extensive first-pass hepatic metabolism, primarily mediated by the cytochrome P450 2D6 (CYP2D6) isoenzyme system. Active metabolites include mesoridazine and sulforidazine, both of which contribute to the drug’s therapeutic and adverse profile. Thioridazine exhibits high plasma protein binding, exceeding 90%. The elimination half-life of thioridazine and its primary active metabolites ranges from 24 to 36 hours. Excretion occurs via both renal and biliary elimination pathways.
Safety Considerations, Risks, and Patient Guidance
Adverse reactions
Thioridazine therapy carries a distinct side effect profile. Central nervous system adverse reactions include drowsiness, sedation, dizziness, and extrapyramidal symptoms such as muscle rigidity, tremors, and akathisia. Autonomic effects resulting from anticholinergic blockade include dry mouth, blurred vision, urinary retention, and severe constipation. Orthostatic hypotension may occur, particularly during initial dose titration. Long-term use introduces the risk of tardive dyskinesia, a potentially irreversible neurological condition characterized by involuntary choreoathetotic movements. Endocrine disturbances, including hyperprolactinemia, may lead to gynecomastia, galactorrhea, or menstrual irregularities.
Red flags
Immediate emergency medical attention is required if patients experience signs of severe cardiac arrhythmias, such as sudden palpitations, syncope, severe lightheadedness, or loss of consciousness. Symptoms indicative of neuroleptic malignant syndrome (NMS)–a rare but life-threatening emergency characterized by high fever, severe muscle stiffness, altered mental status, and autonomic instability–require immediate hospital evaluation. Patients demonstrating signs of severe hypersensitivity, such as swelling of the face, lips, tongue, or throat, or severe cutaneous reactions with blistering, must seek emergency assistance right away. Sudden jaundice or dark urine also warrants urgent clinical evaluation.
Important precautions
Mellaril carries a Boxed Warning regarding dose-related QTc interval prolongation, which can precipitate Torsades de Pointes, a severe and potentially fatal ventricular arrhythmia. Consequently, baseline electrocardiogram (ECG) testing and serum potassium/magnesium monitoring are mandatory prior to treatment initiation and periodically during therapy. Mellaril is contraindicated in patients with congenital long QT syndrome, cardiac arrhythmias, severe heart failure, or uncorrected hypokalemia or hypomagnesemia. Furthermore, elderly patients with dementia-related psychosis treated with antipsychotic medications face an increased risk of death; Mellaril is not approved for dementia-related psychosis.
What not to combine
Co-administration of Mellaril with medications that inhibit the CYP2D6 enzyme–such as fluoxetine, paroxetine, quinidine, and fluvoxamine–is strictly contraindicated because it causes elevated plasma concentrations of thioridazine, exponentially increasing cardiotoxicity risks. Combining thioridazine with other pharmaceuticals known to prolong the QTc interval, including class IA and III antiarrhythmics (such as quinidine, sotalol, or amiodarone), macrolide antibiotics, and certain fluoroquinolones, is also prohibited. Concomitant use with central nervous system depressants, including alcohol, opioids, and sedatives, produces additive central depression.
What to avoid while taking it
Alcohol consumption must be strictly avoided during treatment with Mellaril, as ethanol potentiates central nervous system depression and increases the severity of drowsiness and orthostatic hypotension. Patients should avoid activities leading to dehydration or electrolyte depletion, as hypokalemia or hypomagnesemia significantly raises the risk of fatal ventricular arrhythmias. Doses may be taken with food to minimize potential gastrointestinal discomfort, provided administration remains consistent.
Special populations
The safety and efficacy of Mellaril in pediatric patients have not been established, and its use in children is generally avoided. In pregnant women, thioridazine should be used only if the potential benefit justifies the risk; infants exposed to antipsychotics during the third trimester of pregnancy face risks of extrapyramidal or withdrawal symptoms post-delivery. Thioridazine is excreted into breast milk, making breastfeeding during treatment unadvisable. Elderly individuals often exhibit heightened sensitivity to anticholinergic and hypotensive effects, necessitating conservative dosing and close monitoring.
Practical tips
Patients must take Mellaril exactly as directed by their healthcare provider and should never alter doses independently. Patients should transition slowly from sitting or lying positions to standing to mitigate orthostatic hypotension and prevent falls. Hazardous activities requiring mental alertness, such as driving or operating machinery, should be avoided until individual tolerance is determined. Store the medication at controlled room temperature between 68°F and 77°F (20°C to 25°C), away from excess heat, moisture, and light.
Common questions
What should be done if a dose of Mellaril is missed?
If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next scheduled dose. Patients must not double the dose to make up for a missed administration, as elevated serum concentrations increase the danger of cardiac conduction abnormalities.
Why are baseline ECGs required before starting Mellaril?
Baseline ECGs are required to measure the patient’s underlying QTc interval. Because thioridazine can prolong the QTc interval in a dose-dependent manner, identifying baseline abnormalities helps prevent exposing high-risk patients to fatal cardiac arrhythmias.
Can Mellaril be stopped abruptly?
Abrupt cessation of thioridazine can cause withdrawal symptoms, including nausea, vomiting, dizziness, tremulousness, and a rapid relapse of psychotic symptoms. Gradual dose reduction under direct medical supervision is standard practice when discontinuing therapy.
How does CYP2D6 metabolizer status influence Mellaril safety?
Individuals classified as poor CYP2D6 metabolizers clear thioridazine significantly slower than extensive metabolizers. This leads to higher drug accumulation in the bloodstream, elevated QTc prolongation risks, and increased susceptibility to severe toxicities.
Is driving permitted while taking Mellaril?
Driving or operating heavy machinery is not recommended, particularly during treatment initiation or dose adjustments. Thioridazine frequently impairs physical coordination, vigilance, and reaction times due to its central nervous system depressant effects.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.
Additional information
| Dosage |
10mg ,25mg ,50mg ,100 mg |
|---|---|
| Package |
10 pills ,20 pills ,30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Asendin
$ 41,00 – $ 369,00Price range: $ 41,00 through $ 369,00
Active substance: Amoxapine
More Details
This product has multiple variants. The options may be chosen on the product page
Celexa
$ 7,00 – $ 193,00Price range: $ 7,00 through $ 193,00
Active substance: Citalopram
More Details
This product has multiple variants. The options may be chosen on the product page
Duzela
$ 36,00 – $ 83,00Price range: $ 36,00 through $ 83,00
Active substance: Duloxetine
More Details
This product has multiple variants. The options may be chosen on the product page
Emsam
$ 66,00 – $ 345,00Price range: $ 66,00 through $ 345,00
Active substance: Selegiline
More Details
This product has multiple variants. The options may be chosen on the product page
Lexapro
$ 40,00 – $ 265,00Price range: $ 40,00 through $ 265,00
Active substance: Escitalopram
More Details
This product has multiple variants. The options may be chosen on the product page
Pamelor
$ 54,00 – $ 185,00Price range: $ 54,00 through $ 185,00
Active substance: Nortriptyline
More Details
This product has multiple variants. The options may be chosen on the product page
Paroxetine
$ 44,00 – $ 321,00Price range: $ 44,00 through $ 321,00
Active substance: paroxetine
More Details
This product has multiple variants. The options may be chosen on the product page
Pexep
$ 42,00 – $ 162,00Price range: $ 42,00 through $ 162,00
Active substance: paroxetine
More Details
This product has multiple variants. The options may be chosen on the product page
